11 minutes to Read

Current management of type 2 diabetes includes two new classes of medication, SGLT2 inhibitors and GLP-1 receptor agonists, where clinically indicated. This article was published in the April 2021 edition of Kai Tiaki. It has been edited specifically for our nursing readership from an article that appeared in New Zealand Doctor and Pharmacy Today late in 2020. 

This article is endorsed by the College of Nurses Aotearoa (NZ) Inc.

Contributor
Dr Rinki Murphy, Lisa Sparks
9 April 2021

We are pleased to be providing educational content to the New Zealand Nurses Organisation for publication in Kai Tiaki Nursing New Zealand. Our first contribution, "How to change lives: Prescribing equity through better use of medicines", appears in the February issue of Kai Tiaki Nursing New Zealand and is part of a course endorsed by CNA(NZ) for 1.5 hours of professional development. 

To complete the course, click here to go to ELearning.

Contributor
Interviews by Michael Botur
10 February 2021